Foresite Capital

Foresite Capital Foresite Capital, founded in 2011 by Jim Tananbaum MD, manages $3.5B-plus, making it one of the largest dedicated healthcare and life sciences VCs. Fund VI closed at $900M in June 2024. Check sizes range from $2M to $75M, backing approximately 20 companies per fund through the full investment lifecycle. The portfolio demonstrates deep tech conviction in genomics and precision medicine: 10x Genomics (genomic analysis platform, NYSE: TXG), Pacific Biosciences (long-read sequencing)